Safety Profile of Desmopressin Tablet for Enuresis in a Prospective Study
Conclusion
Desmopressin tablet treatment is well tolerated in children with primary nocturnal enuresis, regardless of patient gender or age.
Funding
The desmopressin response in primary nocturnal enuresis study (DRIP- study) was funded by Ferring.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Bed Wetting | Children | Drugs & Pharmacology | Enuresis | Gastroenterology | Respiratory Medicine | Study